From 11:00 pm to 12:00 pm EST ( 8:00 pm to 9:00 pm PST ) on January 6th, the website will be under maintenance. We are sorry for the inconvenience. Please arrange your schedule properly.
BMS-433771 is a potent orally active inhibitor of respiratorysyncytialvirus(RSV). BMS-433771 is active against both A and B groups of RSV, with an average EC50 of 20 nM. BMS-433771 can be used for the research of respiratory tract disease .
BMS-433771 dihydrochloride hydrate is a potent orally active inhibitor of respiratorysyncytialvirus(RSV). BMS-433771 dihydrochloride hydrate is active against both A and B groups of RSV, with an average EC50 of 20 nM. BMS-433771 dihydrochloride hydrate can be used for the research of respiratory tract disease .
Motavizumab (MEDI-524) is an anti-human RSV(respiratorysyncytialvirus) monoclonal antibody. Motavizumab can be used in respiratorysyncytialvirus infection in high-risk infants research .
RSV604 R enantiomer is the R-enantiomer of RSV604. RSV604 is an inhibitor of respiratorysyncytialvirus (RSV) replication. R-enantiomer is less active against RSV.
SyncytialVirus Inhibitor-1 is a potent, orally bioavailable respiratorysyncytialvirus(RSV) fusion inhibitor with EC50s of 0.002 μM, 0.004 μM, and 0.002 μM for RSV Long, RSV A2, and RSV B strains, respectively .
RSV-IN-3 (Compound 1) is a dual inhibitor of respiratorysyncytialvirus(RSV) and influenza virus A (IAV). RSV-IN-3 shows anti-RSV activity (EC50 = 32.70 μM) .
RSV-IN-4 (Compound 2) is a dual inhibitor of respiratorysyncytialvirus(RSV) and influenza virus A (IAV). RSV-IN-4 shows anti-RSV activity (EC50 = 11.76 μM) .
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratorysyncytialvirus infection .
ALS-8112 is a potent and selective respiratorysyncytialvirus(RSV) polymerase inhibitor. The 5'-triphosphate form of ALS-8112 inhibits RSV polymerase with an IC50 of 0.02 μM.
PC786 is an inhaled respiratorysyncytialvirus(RSV) L protein polymerase inhibitor. PC786 demonstrates potent antiviral activity against RSV-A (IC50 <0.09 to 0.71 nM) and RSV-B (IC50, 1.3 to 50.6 nM) .
RFI-641 is a selective inhibitor of the respiratorysyncytialvirus(RSV), with an IC50 of 50 nM. RFI-641 inhibit binding and fusion of enveloped virus via interaction with the viral fusion protein .
Nirsevimab (MEDI8897) is a recombinant human respiratorysyncytialvirus(RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research .
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratorysyncytialvirus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species .
RSV604 (A-60444) is an inhibitor of respiratorysyncytialvirus(RSV) replication. RSV604 targets the nucleocapsid protein, with a Kd of 1.6 μM. RSV604 displays submicromolar activity against numerous clinical isolates of both the A and B subtypes of RSV (average EC50s=0.8 μM) .
JNJ 2408068 is a potent RSV (respiratorysyncytialvirus) inhibitor. JNJ 2408068 significantly inhibits replication of RSV A and B subtypes in the lungs of cotton rats without any evidence of toxicity. The minimum protective dose of JNJ 2408068 appears to be approximately 0.39 mg/kg .
4-Methoxycinnamaldehyde (p-Methoxycinnamaldehyde), an active constituent of Agastache rugosa, exhibits cytoprotective activity against respiratorysyncytialvirus(RSV) in human larynx carcinoma cell line. 4-Methoxycinnamaldehyde effectively inhibits cytopathic effect of RSV with an estimated IC50 of 0.055 μg/mL .
Sophoranol is an alkaloid that can be isolated from S. flavescens, with antiviral activity. Sophoranol has anti-HBV (hepatitis B virus) activity. Sophoranol shows potent antiviral activities against respiratorysyncytialvirus (RSV) with an IC50 of 10.4 μg/mL .
4,5-O-Dicaffeoyl quinic acid methyl ester (compound 4), a dicaffeoylquinic acid, has potent antiviral activity against respiratorysyncytialvirus(RSV) with an IC50 of 0.63 μg/mL and a CC50 of 118.68 μg/mL.
RSV-IN-5 (Compound 4) is a potent dual inhibitor of wild-type and mutant respiratorysyncytialvirus(RSV) fusion proteins. RSV-IN-5 exhibits potent anti-RSV activities against not only wild-type A2 F protein (EC50=2.0 nM), but also D486N-mutant F protein (EC50=8.1 nM) .
Ac-CoA Synthase Inhibitor1 is a potent, reversible acetate-dependent acetyl-CoA synthetase 2 (ACSS2) inhibitor with an IC50 of 0.6 µM . Ac-CoA Synthase Inhibitor1 inhibits the respiratorysyncytialvirus(RSV) .
Rostafuroxin (PST 2238), a digitoxigenin derivative, is an orally active and potent Na +,K +-ATPase (ATP1A1) antognist. Rostafuroxin binds specifically to the ATP1A1 extracellular domain and blocks respiratorysyncytialvirus(RSV)-triggered EGFR Tyr845 phosphorylation. Rostafuroxin has antihypertensive and anti-RSV activity .
RSV/IAV-IN-3 (compound 14'i) is a dual inhibitor of respiratorysyncytialvirus(RSV) and influenza A virus (IAV) with EC50 values of 2.92 µM and 1.90 µM,respectively. RSV/IAV-IN-3 has antiviral effect against H1N1 and H3N2 with EC50 values of 3.25 µM and 1.50 µM in MDCK cells, respectively. RSV/IAV-IN-3 significantly inhibits the activity of luciferase in a dose-dependent manner, with an EC50 of 3.89 µM. RSV/IAV-IN-3 inhibits IAV infectivity and RdRp activity. RSV/IAV-IN-3 inhibits IAV and RSV replication at the post-entry stage .
3,4-Di-O-caffeoyl quinic acid methyl ester (Macroantoin F) is a dicaffeoyl derivative isolated from the rhizome of Elephantopus scaber Linn. 3,4-Di-O-caffeoyl quinic acid methyl ester exhibited in vitro antiviral activity against respiratorysyncytialvirus(< a href=" " class="link-product" target="_blank">RSV) with an IC50 value of 0.78 μg/mL .
AVG-233 is a potent, orally active RNA dependent RNA polymerase (RdRp) inhibitor. AVG-233 prevents initiation of the viral polymerase complex at the promoter. AVG-233 binding site is present in the L1-1749 fragment. AVG-233 has nanomolar activity against both RSV strains and clinical RSV isolates (EC50=0.14-0.31 μM). AVG-233 can be used for research of respiratorysyncytialvirus (RSV) .
Mindeudesivir (JT001; VV116; GS-621763-d1) hydrobromide is a deuterated version of Remdesivir (HY-104077), a highly orally active nucleoside antiviral against SARS-CoV-2 and respiratorysyncytialvirus(RSV). Mindeudesivir hydrobromide retains the antiviral activity of Remdesivir against COVID-19, and is the first domestically produced deuterium targeting the COVID-19 .
Motavizumab (MEDI-524) is an anti-human RSV(respiratorysyncytialvirus) monoclonal antibody. Motavizumab can be used in respiratorysyncytialvirus infection in high-risk infants research .
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratorysyncytialvirus infection .
Nirsevimab (MEDI8897) is a recombinant human respiratorysyncytialvirus(RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research .
4-Methoxycinnamaldehyde (p-Methoxycinnamaldehyde), an active constituent of Agastache rugosa, exhibits cytoprotective activity against respiratorysyncytialvirus(RSV) in human larynx carcinoma cell line. 4-Methoxycinnamaldehyde effectively inhibits cytopathic effect of RSV with an estimated IC50 of 0.055 μg/mL .
Sophoranol is an alkaloid that can be isolated from S. flavescens, with antiviral activity. Sophoranol has anti-HBV (hepatitis B virus) activity. Sophoranol shows potent antiviral activities against respiratorysyncytialvirus (RSV) with an IC50 of 10.4 μg/mL .
4,5-O-Dicaffeoyl quinic acid methyl ester (compound 4), a dicaffeoylquinic acid, has potent antiviral activity against respiratorysyncytialvirus(RSV) with an IC50 of 0.63 μg/mL and a CC50 of 118.68 μg/mL.
3,4-Di-O-caffeoyl quinic acid methyl ester (Macroantoin F) is a dicaffeoyl derivative isolated from the rhizome of Elephantopus scaber Linn. 3,4-Di-O-caffeoyl quinic acid methyl ester exhibited in vitro antiviral activity against respiratorysyncytialvirus(< a href=" " class="link-product" target="_blank">RSV) with an IC50 value of 0.78 μg/mL .
RSV G protein is a type II, highly glycosylated membrane protein with a full length of 292-319 amino acids (aa), an intracellular cytoplasmic tail (aa 1-37), and a transmembrane domain (aa 38 -66) and the extracellular domain ending in its carboxyl terminus. The RSV G protein has broad effects on the biology of RSV infection as well as host immune responses and infection-associated diseases. glycoprotein/G Protein, HRSV (258a.a, HEK293, His) is the recombinant Virus-derived glycoprotein/G protein, expressed by HEK293 , with C-His labeled tag. The total length of glycoprotein/G Protein, HRSV (258a.a, HEK293, His) is 258 a.a., with molecular weight of ~29.59 kDa.
The glycoprotein/G Protein, crucial in the immune response, forms the interleukin-31 receptor with OSMR. This receptor activates STAT3, and to a lesser extent, STAT1 and STAT5, playing a vital role in skin immunity and mediating IL31-induced itch, potentially involving TRPA1 and TRPV1. It positively regulates myeloid progenitor cell numbers and cycling status in the bone marrow, enhancing survival. Acting in viral infection, the glycoprotein/G Protein attaches the virion to the host cell membrane, interacts with heparan sulfate, modulates the immune response through CX3CR1, and aids in escaping antibody-dependent restriction by acting as an antigen decoy. glycoprotein/G Protein, HRSV (sf9, His) is the recombinant Virus-derived glycoprotein/G protein, expressed by Sf9 insect cells, with C-His labeled tag. The total length of glycoprotein/G Protein, HRSV (sf9, His) is 232 a.a., with molecular weight of 40-55 kDa.
F0/F is a class of viral fusion proteins that, as an inactive precursor, are cleaved by a furfurin-like protease at two sites to produce mature F1 and F2 fusion glycoproteins. The F protein can mediate cell-cell fusion, lead to syncytial formation, and trigger p53-dependent apoptosis in the later stages of infection. Fusion glycoprotein F0/F Protein, HRSV (AFX60213, sf9, His) is the recombinant Virus-derived Fusion glycoprotein F0/F protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Fusion glycoprotein F0/F Protein, HRSV (AFX60213, sf9, His) is 500 a.a., with molecular weight of ~57.12 kDa.
F0/F is a class of viral fusion proteins that, as an inactive precursor, are cleaved by a furfurin-like protease at two sites to produce mature F1 and F2 fusion glycoproteins. The F protein can mediate cell-cell fusion, lead to syncytial formation, and trigger p53-dependent apoptosis in the later stages of infection. Fusion glycoprotein F0/F Protein, HRSV (AHX57537, sf9, His) is the recombinant Virus-derived Fusion glycoprotein F0/F protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Fusion glycoprotein F0/F Protein, HRSV (AHX57537, sf9, His) is 526 a.a., with molecular weight of ~57.04 kDa.
The glycoprotein/G Protein, crucial in the immune response, forms the interleukin-31 receptor with OSMR. This receptor activates STAT3, and to a lesser extent, STAT1 and STAT5, playing a vital role in skin immunity and mediating IL31-induced itch, potentially involving TRPA1 and TRPV1. It positively regulates myeloid progenitor cell numbers and cycling status in the bone marrow, enhancing survival. Acting in viral infection, the glycoprotein/G Protein attaches the virion to the host cell membrane, interacts with heparan sulfate, modulates the immune response through CX3CR1, and aids in escaping antibody-dependent restriction by acting as an antigen decoy. glycoprotein/G Protein, HRSV (93% Homology, HEK293, His) is the recombinant Virus-derived glycoprotein/G protein, expressed by HEK293, with C-His labeled tag. The total length of glycoprotein/G Protein, HRSV (93% Homology, HEK293, His) is 232 a.a., with molecular weight of 60-90 kDa.
A glycoprotein/G protein critical in the immune response forms the interleukin-31 receptor with OSMR. This receptor activates STAT3 and, to a lesser extent, STAT1 and STAT5, playing a critical role in skin immunity and mediating IL31-induced itch, possibly involving TRPA1 and TRPV1. Glycoprotein/G Protein, HRSV (95% Homology, HEK293, His) is the recombinant Virus-derived Glycoprotein/G protein, expressed by HEK293 , with C-His labeled tag. The total length of Glycoprotein/G Protein, HRSV (95% Homology, HEK293, His) is 232 a.a., with molecular weight of ~50-100 kDa.
The fusion glycoprotein F0/F protein is cleaved to generate mature F1 and F2 fusion glycoproteins. It functions as a viral fusion protein, promoting the fusion of virus and cell membranes through different state transitions. Fusion glycoprotein F0/F Protein, HRSV (P11209, sf9, His) is the recombinant Virus-derived Fusion glycoprotein F0/F protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Fusion glycoprotein F0/F Protein, HRSV (P11209, sf9, His) is 529 a.a., with molecular weight of ~63 kDa.
The fusion glycoprotein F0/F protein is initially an inactive precursor that is cleaved by furin-like proteases to produce the mature F1 and F2 fusion glycoproteins. As a class I viral fusion protein, it undergoes prefusion, prehairpin, and postfusion states. Fusion glycoprotein F0/F Protein, HRSV (sf9, His) is the recombinant Virus-derived Fusion glycoprotein F0/F protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Fusion glycoprotein F0/F Protein, HRSV (sf9, His) is 504 a.a., with molecular weight of 45-55 kDa.
Mindeudesivir (JT001; VV116; GS-621763-d1) hydrobromide is a deuterated version of Remdesivir (HY-104077), a highly orally active nucleoside antiviral against SARS-CoV-2 and respiratorysyncytialvirus(RSV). Mindeudesivir hydrobromide retains the antiviral activity of Remdesivir against COVID-19, and is the first domestically produced deuterium targeting the COVID-19 .
Inquiry Online
Your information is safe with us. * Required Fields.
